Tauro-Obeticholic acid
CAS No. 863239-61-6
Tauro-Obeticholic acid( —— )
Catalog No. M24862 CAS No. 863239-61-6
Tauro-Obeticholic acid is an active Obeticholic acid metabolite. Obeticholic acid is an orally bioavailable agonist of farnesoid-X receptor (FXR).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 350 | In Stock |
|
| 5MG | 275 | In Stock |
|
| 10MG | 414 | In Stock |
|
| 25MG | 686 | In Stock |
|
| 50MG | 918 | In Stock |
|
| 100MG | 1283 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTauro-Obeticholic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionTauro-Obeticholic acid is an active Obeticholic acid metabolite. Obeticholic acid is an orally bioavailable agonist of farnesoid-X receptor (FXR).
-
DescriptionTauro-Obeticholic acid is an active Obeticholic acid metabolite. Obeticholic acid is an orally bioavailable agonist of farnesoid-X receptor (FXR).
-
In VitroObeticholic acid is conjugated with taurine in the liver to form Tauro-obeticholic acid, which is secreted into bile. Microorganisms in the ileum and colon can deconjugate Tauro-obeticholic acid, converting it into the parent drug, which may then be reabsorbed or excreted in faeces.
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetFXR
-
RecptorFXR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number863239-61-6
-
Formula Weight527.76
-
Molecular FormulaC28H49NO6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@H](CCC(NCCS(=O)(O)=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Markham A, et al. Obeticholic Acid: First Global Approval. Drugs. 2016 Aug;76(12):1221-6.
molnova catalog
related products
-
Nidufexor
Nidufexor (LMB763, LMB-763) is a novel potent farnesoid X receptor (FXR) agonist?for the treatment of non-alcoholic steatohepatitis (NASH) and hepatobiliary disorders.
-
GSK-2324
GSK-2324 (GSK2324)?is a potent, selective, full FXR agonist with EC50 of 120 nM in FRET assay.
-
INT-747
INT-747(Obeticholic acid, 6-ECDCA, 6-Ethylchenodeoxycholic acid)?is a potent and selective FXR agonist (EC50=99 nM).
Cart
sales@molnova.com